Clinical Trial Update: Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) [Phase 3]

View source ↗

Summary

A Phase 3 study in Japanese adults evaluated the efficacy and safety of rimegepant (Nurtec ODT) for acute treatment of migraine; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2025-02-10